Whole brain irradiation with simultaneous integrated boost  in treatment of oligometastatic brain disease

Goran Kolarevic; Dražan  Jaroš; Dejan  Ćazić; Dejan Djokanović

doi:10.2298/VSP161217145K

Goran Kolarevic International Medical Centers, Affidea, Center for Radiation Therapy, Banja Luka, Bosnia and Herzegovina
Dražan Jaroš International Medical Centers, Affidea, Center for Radiation Therapy, Banja Luka, Bosnia and Herzegovina
Dejan Ćazić International Medical Centers, Affidea, Center for Radiation Therapy, Banja Luka, Bosnia and Herzegovina
Dejan Djokanović University Clinical Centre of the Republic of Srpska, Oncology Clinic, Banja Luka, Bosnia and Herzegovina

DOI: https://doi.org/10.2298/VSP161217145K

Keywords: brain, neoplasm metastasis, radiation oncology, radiotherapy, diagnosis, computer-assisted, radiotherapy, adjuvant, prognosis, mortality

Abstract

Abstract

Background/Aim. Brain metastases occur in 20%–30% of all patients with systemic cancer. We aimed at investigating whether patients with oligometastatic brain disease treated with whole brain radiotherapy (WBRT) and simultaneous integrated boost of brain metastases (SIB_mets) improved overall survival (clinical outcomes) compared with patients from the Radiation Therapy Oncology Group (RTOG) 9508 database, treated with WBRT and sequential stereotactic radiosurgery (SRS) boost. Methods. WBRT with SIB_mets, using the RapidArc (RA) (Varian Medical Systems, Palo Alto, CA) volumetric modulated arc technique (VMAT), was delivered to 15 patients with computed tomography/magnetic resonance imaging (CT/MRI) findings of 1–3 brain metastases with a diameter less than 40 mm for the largest lesion. Radiotherapy (RT) plans consisted of WBRT, with a prescribed dose of 20 Gy in 5 fractions, with SIB_mets which was also 20 Gy (gray units) in 5 fractions. Results. A group of 15 patients included 8 males and 7 females with the mean age of 56.3 years. Three patients were in the RTOG Recursive Partitioning Analysis (RPA) Class I and other 12 patients in RPA Class II. Four patients had one metastasis and 11 patients had two metastases. Calculated mean survival time (MST) was 7.49 ± 4.36 months with no statistically significant difference compared to RTOG 9508 results (MST = 6.5 months) (p = 0.197). The local control rate for 7 patients after three months was 85.7%. Conclusion. WBRT with SIB_mets and WBRT + SRS are clinically equivalent treatment options for the patients with oligometastatic brain disease. In comparison to the WBRT + SRS, the treatment by WBRT + SIB_mets technique reduces the treatment time and improves the patient’s treatment comfort.

Author Biography

Goran Kolarevic, International Medical Centers, Affidea, Center for Radiation Therapy, Banja Luka, Bosnia and Herzegovina

Center for Radiotherapy

Chief medical physicist

References

REFERENCES

Patchell RA. Brain metastases. Neurol Clin 1991; 9(4): 817–24.

Schouten LJ, Rutten J, Huveneers HA, Twijnstra A. Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma. Cancer 2002; 94(10): 2698–705.

McTyre E, Scott J, Chinnaiyan P. Whole brain radiotherapy for brain metastasis. Surg Neurol Int 2013; 4(Suppl 4): S236–44.

Sejpal SV, Bhate A, Small W. Palliative radiation therapy in the management of brain metastases, spinal cord compression, and bone metastases. Semin Intervent Radiol 2007; 24(4): 363–74.

Andrews DW, Scott CB, Sperduto PW, Flanders AE, Gaspar LE, Schell MC, et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: Phase III results of the RTOG 9508 randomised trial. Lancet 2004; 363(9422): 1665–72.

Gaspar L, Scott C, Rotman M, Asbell S, Phillips T, Wasserman T, et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 1997; 37(4): 745–51.

Lagerwaard LJ, Eppinga WS, Haasbeek CJ, de Haan PF, Slotman BJ. Whole Brain Radiotherapy with Simultaneous Integrated Boost (WBRT+SIB) for Multiple Brain Metastases (BM) using Volumetric Modulated Arc Therapy. Int J Radiat Oncol Biol Phys 2010; 73(3): 677.

Rich JT, Neely GJ, Paniello RC, Voelker CC, Nussenbaum B, Wang EW. A practical guide to understanding Kaplan-Meier curves. Otolaryngol Head Neck Surg 2010; 143(3): 331–6.

Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tu-mours: Revised RECIST guideline (version 1.1). Eur J Cancer 2009; 45(2): 228–47.

Patchell RA, Tibbs PA, Regine WF, Dempsey RJ, Mohiuddin M, Kryscio RJ, et al. Postoperative radiotherapy in the treatment of single metastases to the brain: A randomized trial. JAMA 1998; 280(17): 1485–9.

Aoyama H, Shirato H, Tago M, Nakagawa K, Toyoda T, Hatano K, et al. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: A randomized controlled trial. JAMA 2006; 295(21): 2483–91.

Patchell RA, Tibbs PA, Walsh JW, Dempsey RJ, Maruyama Y, Kryscio RJ, Young B. A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 1990; 322(8): 494–500.

Noordijk EM, Vecht CJ, Haaxma-Reiche H, Padberg GW, Voormolen JH, Hoekstra FH, et al. The choice of treatment of single brain metastasis should be based on extracranial tumor activity and age. Int J Radiat Oncol Biol Phys 1994; 29(4): 711–7.

Mintz AH, Kestle J, Rathbone MP, Gaspar L, Hugenholtz H, Fisher B, et al. A randomized trial to assess the efficacy of surgery in addition to radiotherapy in patients with a single cerebral metastasis. Cancer 1996; 78(7): 1470–6.

Kocher M, Soffietti R, Abacioglu U, Villà S, Fauchon F, Baumert BG, et al. Adjuvant whole brain radiotherapy versus observation after radiosurgery or surgical resection of 1-3 cerebral metastases: Results of EORTC 22952-26001 study. J Clin Oncol 2009; 29(2): 134–41.

Scoccianti S, Ricardi U. Treatment of brain metastases: Review of phase III randomized controlled trials. Radiother Oncol 2012; 102(2): 168–79.

Kondziolka D, Patel A, Lunsford LD, Kassam A, Flickinger JC. Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. Int J Radiat Oncol Biol Phys 1999; 45(2): 427–34.